22,23-dihydrobrassicasterol

22,23-dihydrobrassicasterol is a lipid of Sterol Lipids (ST) class. 22,23-dihydrobrassicasterol is associated with abnormalities such as Diabetes, Macular degeneration, Drusen, Systemic disease and Diabetes Mellitus. The involved functions are known as cholesterol metabolism, Synthesis, Intestinal Absorption, Liver function and cholesterol absorption. 22,23-dihydrobrassicasterol often locates in Back and Cell membrane. The associated genes with 22,23-dihydrobrassicasterol are apolipoprotein E-3. The related lipids are Total cholesterol, campesterol, lathosterol, Fatty Acids, Nonesterified and Cholesterol, Dietary.

Cross Reference

Introduction

To understand associated biological information of 22,23-dihydrobrassicasterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22,23-dihydrobrassicasterol?

22,23-dihydrobrassicasterol is suspected in Diabetes, Macular degeneration, Drusen, Systemic disease, Diabetes Mellitus, Liver diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22,23-dihydrobrassicasterol

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypolipoproteinemias D007009 9 associated lipids
Xanthomatosis D014973 17 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 22,23-dihydrobrassicasterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22,23-dihydrobrassicasterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22,23-dihydrobrassicasterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22,23-dihydrobrassicasterol

Download all related citations
Per page 10 20 50 100 | Total 313
Authors Title Published Journal PubMed Link
Lembcke J et al. Rapid quantification of free and esterified phytosterols in human serum using APPI-LC-MS/MS. 2005 J. Lipid Res. pmid:15489546
Jakulj L et al. Plasma plant sterols serve as poor markers of cholesterol absorption in man. 2013 J. Lipid Res. pmid:23178226
Silbernagel G et al. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. 2010 J. Lipid Res. pmid:20228406
Jakulj L et al. Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial. 2010 J. Lipid Res. pmid:19828909
Matthan NR et al. Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial. 2010 J. Lipid Res. pmid:19578163
Wewer V et al. Quantification of sterol lipids in plants by quadrupole time-of-flight mass spectrometry. 2011 J. Lipid Res. pmid:21382968
Howell TJ et al. Phytosterols partially explain differences in cholesterol metabolism caused by corn or olive oil feeding. 1998 J. Lipid Res. pmid:9555952
Gylling H et al. Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population. 1999 J. Lipid Res. pmid:10191283
Vanmierlo T et al. Dietary intake of plant sterols stably increases plant sterol levels in the murine brain. 2012 J. Lipid Res. pmid:22279184
Field FJ et al. Effect of micellar beta-sitosterol on cholesterol metabolism in CaCo-2 cells. 1997 J. Lipid Res. pmid:9162754
Lütjohann D et al. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. 1995 J. Lipid Res. pmid:7595097
Yu L et al. Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8. 2005 J. Lipid Res. pmid:15930515
Shafaati M et al. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. 2011 J. Lipid Res. pmid:21335619
Plat J et al. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. 2005 J. Lipid Res. pmid:15520451
Kuriyama M et al. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis. 1991 J. Lipid Res. pmid:2066659
Salen G et al. Hyperabsorption and retention of campestanol in a sitosterolemic homozygote: comparison with her mother and three control subjects. 2000 J. Lipid Res. pmid:11060358
Relas H et al. Fate of intravenously administered squalene and plant sterols in human subjects. 2001 J. Lipid Res. pmid:11369807
Pinedo S et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population Study. 2007 J. Lipid Res. pmid:17074925
Del Puppo M et al. Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway. 1998 J. Lipid Res. pmid:9831637
van Himbergen TM et al. Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. 2009 J. Lipid Res. pmid:19043140